TEVA - Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Limited is a global leader in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company's portfolio includes generic medicines, specialty medicines, and biopharmaceutical products, which are marketed and sold in North America, Europe, Israel, and other international markets.

The company's generic medicine segment offers a broad range of products in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. These products cater to various therapeutic areas, including central nervous system, respiratory, and oncology. Teva also provides active pharmaceutical ingredients and contract manufacturing services to other pharmaceutical companies.

In the specialty medicine segment, Teva focuses on developing and commercializing innovative products for the treatment of complex and chronic diseases. The company's product portfolio includes BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma, as well as GRANIX, TRISENOX, LONQUEX, and TEVAGRASTIM/RATIOGRASTIM. Additionally, Teva offers COPAXONE for the treatment of relapsing forms of multiple sclerosis, AJOVY for the preventive treatment of migraine in adults, and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia.

The company's respiratory portfolio includes ProAir RespiClick inhalation powder, QVAR for the treatment of asthma, BRALTUS, a long-acting muscarinic antagonist, CINQAIR/CINQAERO injection, and DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator. Teva also offers a range of over-the-counter (OTC) products under various brand names, including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA.

Teva has established collaboration agreements with several companies, including MedinCell, Sanofi, Alvotech, and Biolojic Design Ltd., to develop and commercialize new products. The company also has a license agreement with MODAG GmbH. With a rich history dating back to 1901, Teva is headquartered in Tel Aviv, Israel, and is committed to improving the health and well-being of patients around the world.